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Abstract
Purpose of review We review the prevalence of pediatric chronic musculoskeletal pain, the
clinical need, the evidence for pharmacological, psychological, physical and, complemen-
tary approaches to pain management, and the possible future development of interdisci-
plinary and distance care.
Recent findings We summarize the Cochrane Systematic Reviews on pharmacological
interventions, which show a lack of evidence to support or refute the use of all classes
of medication for the management of pain. The trials for NSAIDs did not show any
superiority over comparators, nor did those of anti-depressants, and there are no trials
for paracetamol, or of opioid medications. There are studies of psychological interventions
which show promise and increasing support for physical therapy. The optimal approach
remains an intensive interdisciplinary programmatic treatment, although this service is
not available to most.
Summary 1. Given the absence of evidence, a program of trials is now urgently required to
establish the evidence base for analgesics that are widely prescribed for children and
adolescents with chronic musculoskeletal pain. 2. Until that evidence becomes available,
medicine review is an essential task in this population. 3. We need more examples and
efficacy evaluations of intensive interdisciplinary interventions for chronic pain manage-
ment, described in detail so that researchers and clinicians can unpack possible active
treatment components. 4. Online treatments are likely to be critical in the future. We need
to determine which aspects of treatment for which children and adolescents can be
effectively delivered in this way, which will help reduce the burden of the large number
of patients needing support from a small number of experts.
Introduction
Chronic pain, defined as pain lasting for more than
3 months, is common amongst children and adoles-
cents (also referred to as young people or youth), with
prevalence of pediatric chronic pain ranging between 11
and 38% [1]. The most common types of chronic or
persistent pain for young people include headaches,
recurrent abdominal pain, and musculoskeletal pain
[1]. Pediatric chronic musculoskeletal pain (PCMP),
described as pain in the muscles, ligaments, tendons,
and/or bones lasting for longer than 3 months, will be
the focus of this article. This operationalization of
PCMP includes conditions such as juvenile idiopathic
arthritis (JIA) and fibromyalgia syndrome (FMS). Prev-
alence rates across studies vary widely; prevalence ranges
between 8.5 and 40% for children and adolescents with
chronic musculoskeletal pain, and findings are relatively
consistent in reporting knee, back, and neck as the most
common sites [1]. Prevalence, as well as disability due
to PCMP, increases with age [1]. A recent population-
based evaluation of the annual primary care consulta-
tion for pediatric musculoskeletal problems revealed
that 8% of British children and adolescents present to
primary care for musculoskeletal aches and pains at
least once a year with an observed rise in consultations
with age [2]. However, findings with respect to sex
differences are mixed. While most prevalence studies
report higher levels of musculoskeletal pain in girls
[1], others report higher levels in boys [2, 3] and con-
sultations for a musculoskeletal problem were more
common amongst boys than girls [3]. Further research
to clarify these inconsistencies in prevalence and con-
sultation rates is needed but could be partially ex-
plained by the cause of musculoskeletal pain. For exam-
ple, exercise- or trauma-related causes of the pain are
more prevalent in boys compared to girls [2].
Chronic musculoskeletal pain can also accompany
inflammatory, infective, and malignant musculoskeletal
disease [4]. For instance, despite significant advances in
medical treatments for children with JIA, persistent pain
is a common complaint. Pain has been shown to be a
primary determinant of the lower physical, emotional,
and social functioning in these children [5]. The degree
of disabling pain does not always mirror inflammatory
joint activity, and a growing body of research highlights
the importance of environmental and psychosocial in-
fluences on the pain experience of children, in addition
to the contribution of disease activity [6, 7].
The experience of chronic musculoskeletal pain, irre-
spective of etiology, in childhood and adolescence has
been consistently associated with lower health-related
quality of life in domains such as physical health, psy-
chological, emotional, social, and school functioning
[8]. In particular, children and adolescents suffering
from chronicmusculoskeletal pain report lower physical
functioning, attending school less often compared to
their peers, reduced engagement with social and recrea-
tional activities, poorer sleep quality and fewer hours
asleep, and mental health issues such as higher anxiety
and depressive symptoms [9, 10]. The economic cost
associated with the experienced disability due to pediat-
ric chronic pain are high, with recent figures revealing a
cost of $19.5 billion of chronic pain conditions alone
(i.e., excluding pain associated with other long-term
conditions which might also include pain as a symp-
tom) [11]. Several psychosocial variables, such as paren-
tal responses to pain and catastrophic thinking [12],
have been found to influence disability experienced
due to PCMP, thereby highlighting the need and benefit
of an interdisciplinary approach towards treatment and
management. Furthermore, if untreated, children and
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adolescents with chronic pain are at risk of experiencing
continued persistent pain and associated disability as an
adult [1, 13, 14••]. Consequently, provision of ade-
quate, evidence-based treatment for PCMP is crucial to
offset a lifelong trajectory of disability [15].
In this review, we critically evaluate the evidence for
an interdisciplinary approach towards treatment of
PCMP, which mainly focuses on pharmacological, psy-
chosocial, and physical support. Although evidence for
other aspects of treatment, such as healthy diet, sleep
hygiene, complementary, and alternative medicines
is limited, their potential beneficial role within inte-
grative care will be discussed. While each of the
discussed treatment approaches can be successful
when delivered in isolation, interdisciplinary care
involving pharmacological, physical, psychological,
and alternative therapies is a preferred treatment ap-
proach in this population [15, 16••].
Treatment
Pharmacologic treatment
Pharmacological treatments are usually the first form of treatment for PCMP. If
there is an underlying disease process, then targeted treatments will be used to
address this alongside pain management. Unfortunately, the current pharma-
cological treatments used to treat pain directly (including NSAIDs, opioids, and
anti-depressants) in children and adolescents with pain and stiffness associated
with their PCMP condition(s) are not as effective as one would hope. The
number of analgesics and interventions used is a sign that there are no well-
controlled therapeutic trials in pediatric chronic pain. While there are some
ethical and practical challenges with establishing the efficacy in prospective,
randomized controlled trials of pharmacological drugs in children and ado-
lescents, the bigger challenge is to obtain the interest and support of pharma-
cological companies for such pediatric trials.
A recent Cochrane suite of reviews investigating the efficacy of pharmaco-
logical interventions for children and adolescents with chronic pain found
seven randomized controlled trials delivering NSAIDs to youth with various
forms of JIA, compared to active comparators [17•]. The NSAIDs delivered
included aspirin, celecoxib, fenoprofen, ibuprofen, indomethacin, ketoprofen,
meloxicam, naproxen, and rofecoxib. However, not all trials reported on out-
comes of pain and functioning. For example, only three studies reported pain
relief of 30% or greater, but due to the heterogeneity of samples and drugs
delivered, results could not be combined into a singular meta-analysis. Further,
when assessing each of the three studies individually, NSAIDs were not more
beneficial at reducing pain intensity compared to the active comparators.
Nevertheless, patient global impression of change (one study) and carer global
impression of change (four studies) were mostly positive towards NSAIDs.
There were a number of adverse events identified across the studies, including
serious adverse events and withdrawals due to adverse events. The quality of
evidence for all outcomes ranged from very low to low meaning there is very
little confidence in the effect estimate and the true effect is likely to be sub-
stantially different from the estimate of effect. Overall, the review concluded
that there was no evidence to suggest that NSAIDs were effective in treating
chronic pain, including chronic musculoskeletal pain, in children and adoles-
cents, or that one NSAID was more effective than another [17•].
In other Cochrane reviews, review authors did not find any studies eligible
for inclusion to investigate the efficacy of paracetamol [18•] or opioids [19•] for
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children and adolescents with any chronic pain condition, including PCMP.
Four studies (one study investigating children and adolescents with chronic
widespread pain type 1, delivering gabapentin or amitriptyline) investigated the
effects of anti-depressants in children and adolescents [20]. However, no studies
reported on pain reduction or physical functioning. Similar to NSAIDs, there
were adverse events, including serious adverse events and withdrawals due to
adverse events. Further, quality of evidence was rated as very low.
Taken together, as described previously [21], the lack of evidence to support
the efficacy of any of these therapies in children and adolescents is remarkable.
Following these recent Cochrane reviews, a program of trials is now urgently
required to establish the evidence base for analgesics that are still widely
prescribed for PCMP. Until more evidence becomes available, and the potential
for harm, it will be essential to pro-actively review the medicine intake and
uptake within the context of PCMP. Polypharmacy (i.e., the risk of dosing and
combination errors) and confusion over the utility of previously and currently
prescribed medication is common [4] Consequently, drug withdrawal, detoxi-
fication, and replacement should be carefully managed [4].
Psychological treatment
Psychological therapies typically aim to deliver psychoeducation, reduce pain
intensity, increase functioning, and deliver adaptive coping skills to chil-
dren and adolescents [22, 23]. Such interventions are frequently delivered in
Western chronic pain clinics to children and adolescents with chronic muscu-
loskeletal pain. The content of psychological therapies delivered for PCMP
includes cognitive-behavioral therapy, coping skills training, and exposure and
acceptance therapy.
Cognitive-behavioral therapy (CBT) is themost commonly delivered psycho-
logical therapy for pediatric chronic musculoskeletal pain conditions [24••, 25].
Psychoeducation, usually the first session of psychological interventions, explains
the connection between thoughts, feelings, and behaviors. This is particularly
important for children and adolescents with chronic musculoskeletal pain who
report fatigue and tiredness, stiffness, and pain. Negative thoughts that pain is
unmanageable and avoidance strategies of activities that may cause higher pain
are challenged. Further the connection between low or negative mood and
avoidance behaviors are explained. Therefore, coping strategies when experienc-
ing pain spikes are discussed, so that adaptive behaviors can be practiced [24••].
Skills such as thought stopping/reframing, distraction, problem-solving, relaxa-
tion exercises (e.g., deep breathing, imagery), and pacing (covered in physical
activity section) often make up the remaining session within CBT for PCMP.
Some trials have also delivered psychological treatments to parents in addition to
the child, which include providing parents with information and skills on
adaptive coping skills, healthy lifestyles, and operant conditioning [26, 27].
Systematic reviews investigating the efficacy of psychological therapies for
youth with any type of chronic pain produce small to moderate effects at
reducing pain and disability immediately following treatment, and for up to
12 months following treatment [24••, 25, 29]. However, when combined in a
meta-analysis, psychological treatments are not beneficial at reducing anxiety
and depression symptomology for children and adolescents with chronic pain
conditions. Typically, evidence for psychological interventions is very low or of
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low quality, meaning there is very little confidence in the estimate of effect
[24••, 29]. In 2014, Fisher et al. analyzed chronic musculoskeletal pain as a
pain-specific sub-group [25]. In this meta-analysis, one study investigated
adolescents with JIA [30], two studies included children and adolescents with
FMS [31, 32], and two studies included a mixed sample of chronic pain, which
included children and adolescents with musculoskeletal pain [27, 28]. From
this analysis, the authors found beneficial treatment effects for reducing pain
intensity, disability, and depressive symptoms post-treatment, and for disability
at follow-up [28]. Other outcome effects were notmaintained.Only two studies
contributed to the analysis of the impact on anxiety, and no beneficial effect was
found. Similar to studies investigating other types of chronic pain conditions
(e.g., headache, recurrent abdominal pain [33, 34]), no data were presented in
trials on sleep outcomes and no conclusions can be made on whether psycho-
logical interventions can improve sleep, which is known to increase pain
intensity and be disrupted in children and adolescents with pain [10].
Despite the evidence for CBT from these systematic reviews, pain also
impacts other areas of functioning, not tackled by either treatment ap-
proaches, including school and friendships [35, 36]. Pilot trials have indicated
that peer support can play an important role in supporting adolescents with JIA
[37•]. In an 8-week peer-to-peer trial where adolescents with JIA interacted with
young adults with JIA who had been trained in mentoring, all participants
reported that they would recommend to their peers and reported that they were
better able to manage their symptoms, in comparison to controls [37•]. Al-
though there has been little investigation beyond this trial, social support
interventions may represent an important area to investigate in the future.
Physical therapy and exercise
Physical therapy and exercise is a key component of interdisciplinary treatment
approaches for PCMP. However, systematic research evaluating the effective-
ness within this particular population is scarce [16••]. Beyond educating fam-
ilies on the relevance and importance of regular physical activity engagement
and building this into their child’s daily routing, physical therapy includes
specific exercises aimed at increasing muscle strength and flexibility [38]. Ex-
amples of specific exercises include range of motion, stretching, and moderate
aerobic exercises [38]. While evidence for physical therapy in adults with
chronic musculoskeletal pain is strong [38], which lead to standard recom-
mendations, evidence for PCMP is mixed and there are currently no standard-
ized recommendations of exercise levels. For instance, in youth with juvenile
FMS, exercise therapy has shown a positive impact on physical function, FMS
symptoms, quality of life, and pain [39]. However, a systematic review of
physical exercise for JIA reveals trends towards favorable short-term outcomes
on increasing quality of life, functional ability, and aerobic capacity, but these
effects were neither clinical nor statistically significant [40].
Adherence to the recommended exercise levels is a key challenge identified
by clinicians, particularly for young people [38]. Not only can it be challenging
to incorporate physical activity within a busy daily routine, engaging in physical
activity can increase pain experiences, especially at the beginning of treatment,
for children and adolescents suffering from PCMP [15]. To overcome this
barrier, it is crucial to provide physical therapy within a cognitive-behavioral
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framework, with psychological support and a focus on pacing and goal setting
[15, 16••; see more on goal setting within the section on psychological treat-
ments]. Within this cognitive-behavioral framework, the patient sets his/her
own goals for exercise engagements and plans to reach these goals within a
realistic timeframe, in consultation with a physiotherapist and psychologist
[15]. The evidence of the effectiveness of pacing interventions, for either adult or
pediatric populations, is quite limited however. This lack of evidence is partly
due to the absence of a generally agreed definition of pacing; a systematic review
uncovered a wide range of definitions and operationalization of pacing within
the context of chronic pain treatment. Definitions ranged from general coping
techniques for chronic pain, to defining pacing as a planning strategy to
conserve energy with the goal of increasing the level and range of activities [41].
The most widely used broad definition of pacing was put forward by Nielson
et al. 2013: Bthe regulation of activity level and/or rate in the service of an adaptive goal
or goals^ [42, p., 465]. However, as illustrated by a recently formulated Activity
Pacing Framework [43], the term activity pacing is too broad and is being used
as an overarching label, to refer to subcomponents or to refer to a particular
conceptualization. Such continued use of the term is confusing and untenable.
The need for more clarity on the construct of pacing was highlighted in a recent
meta-analysis revealing positive correlations between measures of pacing and
avoidance [44]. A consensus on a definition, operationalization, and assess-
ment of pacing within interdisciplinary treatment of PCMP will be crucial for
appropriate evaluation of this key component of treatment.
Other treatments
Lifestyle counseling
Accumulating evidence shows a strong association between weight increases,
damage to the musculoskeletal structure, and pain complaints, which particu-
larly impacts the ankles, feet, and knees [45]. Despite this link, to the best of our
knowledge, no research is available on the impact of dietary changes aimed at
managing PCMP. Nevertheless, several integral pain management and self-
management programs do include skills aimed at promoting healthy lifestyle
such as balanced diet and sleep hygiene for both children and their parents [30,
46]. For example, specific to children and adolescents with PCMP, healthy diets
should ensure that calcium levels are appropriate, to facilitate the development
of strong and healthy bones. In some occasions, particularly during winter
months when Vitamin D deficiency is common, calcium levels are monitored,
and Vitamin D supplements need to be considered to maintain optimum
calcium levels [46]. However, only weak evidence is available to support the
benefits of Vitamin D inmanaging chronic pain conditions and this evidence is
limited to adult populations [47].
Further, given the bidirectional associations between musculoskeletal pain
and sleep [10], lifestyle counseling for PCMP conditions often addresses the
critical role of appropriate sleep hygiene [30, 46]. However, there has been little
investigation into the treatment effects for sleep hygiene in children and ado-
lescents with chronic pain in general or PCMP in particular [25]. In a random-
ized controlled trial that compared remotely delivering cognitive-behavioral
therapy to educational control, authors did not find any post-treatment effects
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of sleep quality between groups [26]. Nevertheless, therapies that treat insomnia
in children and adolescents (without chronic pain) are efficacious, and therefore
there is promise in adapting these treatments successfully for PMCP [48].
Occupational therapy
Given the substantial impact of musculoskeletal pain on daily activities, an
interdisciplinary approach towards managing PCMP often includes occupa-
tional therapy. Occupational therapy aims to increase engagement with daily
life tasks despite the presence of PCMP. The implementation of occupational
therapy varies widely and typically includes one or more of the following
approaches: training of motor function, training of skills, instructions on joint
protection, counseling on balancing daily life activities, and/or advice and
instruction in the use of assistive devices and provision of splints [49]. While a
systematic review provides evidence for benefits of comprehensive occupa-
tional therapy as well as instruction on joint protection and provision of splints
on improving pain and functional ability in adults with rheumatoid arthritis
[49], no studies evaluated the benefits of occupational therapy approaches for
children and adolescents with musculoskeletal pain could be identified.
Complementary and alternative medicine
The inclusion of complementary and alternative medicine (CAM) approaches
as part of interdisciplinary treatment for pediatric chronic pain has increased
substantially in the last decade [50], with children and adolescents suffering
from chronic musculoskeletal pain being amongst the highest users of CAM
[51]. CAM is a Bgroup of diverse medical and healthcare approaches that are not
presently considered part of conventional medicine^ [50, p., 453], with approaches
within pediatric chronic pain including hypnosis, massage, acupuncture, art
and music therapy, herbal medicines, and yoga [51]. The implementation and
popularity of these CAM approaches are growing, yet evidence on their effec-
tiveness for improving PCMP remains scarce and there are some current chal-
lenges with evaluating these interventions.
For example, a small number of studies reveal positive attitudes towards
acupuncture (on its own or combined with hypnotherapy) as a pain-relieving
strategy by children and adolescents with chronic pain, including PCMP. While
these positive attitudes support the feasibility and acceptability of acupuncture
[52], there is limited objective evidence for the usage, effectiveness, and cost-
effectiveness of acupuncture within treatment of PCMP [53]. Similarly, al-
though, massage techniques are frequently adopted to relief PCMP, a key prob-
lem with evaluating the effectiveness is the range of implementation of these
massage techniques from delivery by a licensed massage therapist [54] to daily
parent-delivered massage [52]. Despite this, there is preliminary evidence for
the benefit of massage techniques in reducing pain, distress, stiffness, tension,
and discomfort [52, 54]. Finally, yoga is a treatment approach that is gaining in
popularity amongst youth. One pilot feasibility trial in youth with rheumatoid
arthritis found notable improvements of medium to large beneficial effect sizes
in reducing pain, pain disability, mental health, and increasing vitality and self-
efficacy amongst participating youth [55]. However, qualitative reports from
participants further confirm the beneficial impact of yoga on the child’s well-
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being, but quantitative reports did not indicate reduced pain intensity. Quali-
tative data also revealed a lack of continuing with yoga after the short 6-week
program, with an associated diminishing impact of the immediate benefits
[55]. Consequently, preliminary evidence for many CAM interventions is
promising, but we need large scale trials with a substantial long-term follow-up
to make evidence-based recommendations.
Conclusions, challenges, and opportunities
The overview provides a clear picture of the limited and scattered evidence
currently available for managing PCMP. Evaluations of psychological therapies
are well-documented, but there is a continued need for high-quality evaluations
of these therapies and a strong need for more high-quality evidence in the areas
of pharmacological, physical therapy, and CAMS in order to formulate an
evidence-based standard care plan for managing PCMP. It is also important to
point out that most of the available evidence stems from either specific condi-
tions, such as JIA, or samples including any chronic pain problem (i.e., including
headaches, abdominal pain), with few studies focusing on pediatric musculo-
skeletal pain (MSK). Some progress in this area is being made in this area, by
seeking evidence for children and adolescents with MSK pain in psychological
and pharmacological trials. Beyond the lack of evidence, several challenges have
been identified that present opportunities for future work in this area.
Intensive interdisciplinary treatment approaches (sometimes residential)
have received preliminary support and are considered the gold standard for
effective management of chronic pain in children and adolescents, including
PCMP [56]. However, the availability of efficacy data for such intensive pro-
grams is limited. Furthermore, little is known about the cost-effectiveness of
such intensive programs. A recent cost-analysis of one USA-based outpatient,
intensive interdisciplinary program treating any type of pediatric chronic pain
[57•] revealed a substantial reduction in outpatient visits, emergency depart-
ment visits, and inpatient hospitalizations, which resulted in a cost saving for
the hospital of 36,228 USD/patient on yearly basis.While this number does not
include the costs for running the pain program, the authors advocated that these
hospital cost savings would cover the cost associated with running the pain
program [57•]. There is a crucial need for future studies to identify the effective
components of these interdisciplinary packages for managing PCMP and their
cost-effectiveness.
As highlighted earlier, one of the challenges to identify the effective compo-
nents of interdisciplinary treatment is the historical exclusion of children and
adolescents from randomized controlled trials (RCTs) evaluating pharmaco-
logical agents for chronicmusculoskeletal pain. Beyond the ethical and practical
challenges to implement such RCTs, research is largely dependent upon the
interest and support from pharmaceutical companies to develop and evaluate
the effectiveness of medication for PCMP. Unfortunately, this pharmaceutical
interest and support is lacking, which represents a major barrier to overcome in
this area. Other barriers, not exclusive to the evaluation pharmaceutical agents
but applicable to all treatment components, include the need for better trans-
parency of any study design, through registration of protocols and primary
outcome measures as well as the underrepresentation of null findings in peer-
reviewed publications. Such transparency would facilitate a comprehensive
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insight into the effective and active components of interdisciplinary treatment
for PCMP.More systematic and standardized organization of data registries and
controlled access for research purposes is one potential avenue to overcome
these barriers and further this field.
An interesting area that has the potential to overcome the barrier of treat-
ment accessibility in a cost-effective way is the role of remote treatment and
how remote treatment options can be effectively integrated with face-to-face
visits with the treatment team. While remote delivery (mainly including online
delivery) of psychological treatment has grown in popularity and shown to be
efficacious [26, 58••], evaluation of remote delivery of other treatment com-
ponents (e.g., yoga instructions, lifestyle advice) and the integration of remote
delivery with hospital appointments are lacking. The development and evalu-
ation of online resources providing evidence-based support on a variety of
treatment modalities, such as Teens Taking Charge (http://teens.
aboutkidshealth.ca/sites/jia/en/Pages/default.aspx [30]), is growing, but con-
tinued evaluation of their effectiveness and integration within standard care
plans will be crucial and has the potential to provide widespread, evidence-
based care for PCMP.
Lastly, given the growing evidence on the crucial need for effective social
support to be able to engage in daily activities despite experiencing PCMP,
future investigations into (cost-)effective interventions to optimize peer and
teacher support will be invaluable. Preliminary steps in this area are being
made. For instance, a recent pilot peer mentorship program in which young
adults with JIA provide mentorship to adolescents with JIA via Skype calls
reported positive outcomes, with improvement in adolescent’s improved self-
management skills and beliefs in their coping efforts being observed [37•].
Further challenges remain with regard to tailoring such programs to individual
needs, as there was wide variation in the length and number of calls made and
the program was only used amongst females [38]. Peer mentorship by another
person living with the same condition can be valuable and facilitate more
positive interactions with same-age pain-free peers. Furthermore, to the best of
our knowledge, there are no standard guidelines available on how to support
and integrate the child’s teacher within the treatment approach. The school
environment is a paramount part of children’s life, which can be disrupted by
the experience of PCMP. A better understanding of how to facilitate a support-
ive teacher-child relationship [59] and constructive teacher-parent relationship
[60] would be imperative in overcoming this disruptive impact of PCMP on
academic and social functioning.
To conclude, despite the relatively high prevalence of chronic musculoskel-
etal pain in youth, there is a sub-group of patients with severe needs who go
untreated. There remains a lack of awareness of this problem, and so a lack of
evidence for the efficacy or safety of most of our treatments. An absence of
evidence is just that: a gap. In that gap, however, there is industry, creativity, and
innovation. Although the development of pharmacological interventions has
slowed, there is growth in the non-pharmacological field, including advances in
psychological interventions. The optimal model for treatment remains an
interdisciplinary programmatic approach in which different professionals
combine treatment options in the service of the patient’s (or family) individual
needs. However, delivery of services using this model and evaluation of these
programs are rare. A positive first step for PCMP would be an interdisciplinary
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model in which one can bring together therapy and medical staff in a specific
chronic pain clinic, and which utilizes online methods of increasing access to
scarce expertise for this large population of patients.
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